NCT07590024 RAIRI-Guided Adjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma Status RECRUITING Phase PHASE3
NCT07582315 A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy and PD-1/PD-L1 Monoclonal Antibody Therapy(PANKU-BTC01) Status NOT_YET_RECRUITING Phase PHASE3
NCT07580339 Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07570914 Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases Status NOT_YET_RECRUITING Phase PHASE2
NCT07562711 Randomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in High-Risk T3N0 Colorectal Cancer Status RECRUITING Phase PHASE2
NCT07562659 Randomized Controlled Study of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy in Stage I/Low-Risk Stage II Colorectal Cancer Status RECRUITING Phase PHASE2
NCT07561060 Low Rectal Cancer Treated With Total Neoadjuvant Therapy Plus Concurrent Tislelizumab Immunotherapy Status RECRUITING Phase PHASE1/PHASE2
NCT07554521 A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States Status RECRUITING Phase PHASE2
NCT07551479 SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT07549906 Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study Status NOT_YET_RECRUITING Phase PHASE2
NCT07529613 Trastuzumab Deruxtecan Plus Nivolumab Plus Capecitabine Plus Oxaliplatin for HER2 Low Gastric and Gastroesophageal Junction Adenocarcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT07521605 Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07515625 Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07503756 JS212 Combination Therapies in Metastatic Colorectal Cancer Status RECRUITING Phase PHASE2
NCT07494448 Phase Ib/II Study of Zanidatamab Plus Tucatinib and Chemotherapy in HER2-Positive Advanced Breast Cancer Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07490262 A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepatocellular Carcinoma as First-line Treatment. Status RECRUITING Phase PHASE2/PHASE3
NCT07477743 A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT07469306 Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07461454 YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer Status NOT_YET_RECRUITING Phase PHASE3